Virtu Financial’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-5,975
Closed -$229K – 1649
2024
Q1
$229K Buy
+5,975
New +$289K 0.02% 726
2023
Q1
– Sell
-1,976
Closed -$228K – 1840
2022
Q4
$228K Buy
+1,976
New +$230K 0.03% 636
2022
Q2
– Sell
-3,526
Closed -$602K – 1867
2022
Q1
$602K Buy
+3,526
New +$665K 0.04% 339
2021
Q2
– Sell
-1,932
Closed -$409K – 1843
2021
Q1
$409K Buy
+1,932
New +$462K 0.03% 628
2020
Q4
– Sell
-2,488
Closed -$409K – 1646
2020
Q3
$409K Buy
+2,488
New +$410K 0.07% 345
2019
Q4
– Sell
-3,775
Closed -$391K – 1684
2019
Q3
$391K Sell
3,775
-1,683
-31% -$181K 0.03% 608
2019
Q2
$700K Buy
+5,458
New +$758K 0.04% 404
2019
Q1
– Sell
-5,850
Closed -$731K – 1670
2018
Q4
$731K Buy
+5,850
New +$1M 0.04% 357

Other funds holding MED

Virtu Financial's MED Position: Q2 2024 in Review

Virtu Financial sold out of Medifast (MED) in Q2 2024, closing a stake of 5,975 shares — an estimated $229K sold.

Virtu Financial first reported a position in MED in Q4 2018 and held it in 8 quarters. The position peaked at $731K in Q4 2018. 158 funds tracked by Wall St. Rank hold MED as of Q2 2024.

  • Virtu Financial reported no remaining Medifast position as of Q2 2024 after selling out during the quarter.
  • Virtu Financial sold 5,975 Medifast shares in Q2 2024, an estimated $229K.
  • Virtu Financial first reported a position in Medifast in Q4 2018 and held it in 8 quarters.
  • Virtu Financial's Medifast position peaked at $731K in Q4 2018.
  • 158 funds tracked by Wall St. Rank held Medifast as of Q2 2024.

Based on Virtu Financial's 13F filing for Q2 2024, filed 9 Aug 2024.